In our quest to dissect the role of RBBP6 in DKD, we embarked on a novel experimental journey by employing adeno‐associated viruses (AAVs) engineered to silence RBBP6 expression (AAV‐shRBBP6) or to serve as controls (AAV‐Control). Here, RBBP6 is linked to diabetic kidney disease.